Literature DB >> 12695521

Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression.

Hongseob So1, Jaerang Rho, Daewon Jeong, Raekil Park, David E Fisher, Michael C Ostrowski, Yongwon Choi, Nacksung Kim.   

Abstract

We have recently reported the identification of a novel member of the leukocyte receptor family, osteoclast-associated receptor (OSCAR), which has two Ig-like domains and functions as a bone-specific regulator of osteoclast differentiation. Here, we have cloned the OSCAR promoter region to examine its regulation by transcription factors. The 1.7-kb promoter region of the mouse OSCAR gene contains two potential E-box elements for microphthalmia transcription factor (MITF) and three putative PU.1 sites. MITF or PU.1 alone activates the OSCAR reporter construct 5-6-fold, and the combination of MITF and PU.1 synergistically activates the OSCAR reporter activity up to 110-fold. The mRNA expression patterns of MITF, PU.1, and OSCAR in TRANCE-treated (RAW 264.7) or TRANCE/M-CSF-treated cells (primary osteoclasts) reveal that MITF mRNA expression is induced at a much earlier time point than OSCAR gene expression. In contrast to MITF, PU.1 mRNA levels remain relatively constant at all time points, suggesting that TRANCE-induced MITF, not PU.1 expression, is one of the critical regulatory mechanisms for optimal OSCAR expression during osteoclastogenesis. In addition, we have shown that the combination of MITF and constitutively active MKK6-expressing plasmids synergistically activates OSCAR reporter activity. Taken together, our results strongly suggest that PU.1 and MITF transcription factors synergistically activate OSCAR gene expression. Moreover, the activation of OSCAR gene expression by PU.1/MITF is further enhanced by the TRANCE-induced MKK6/p38 signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695521     DOI: 10.1074/jbc.M302940200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Osteoclastogenesis and arthritis.

Authors:  Nicola Maruotti; Maria Grano; Silvia Colucci; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2010-11-11       Impact factor: 3.984

2.  Mitf regulates osteoclastogenesis by modulating NFATc1 activity.

Authors:  Ssu-Yi Lu; Mengtao Li; Yi-Ling Lin
Journal:  Exp Cell Res       Date:  2014-08-22       Impact factor: 3.905

3.  Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation.

Authors:  Junwon Lee; Kabsun Kim; Jung Ha Kim; Hye Mi Jin; Han Kyung Choi; Seoung-Hoon Lee; Hyun Kook; Kyung Keun Kim; Yoshifumi Yokota; Soo Young Lee; Yongwon Choi; Nacksung Kim
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

4.  Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation.

Authors:  Koshiro Tsutsumi; Miho Matsuda; Miho Kotani; Akiko Mizokami; Ayako Murakami; Ichiro Takahashi; Yoshihiro Terada; Takashi Kanematsu; Kiyoko Fukami; Tadaomi Takenawa; Eijiro Jimi; Masato Hirata
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

Review 5.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

6.  SLAT negatively regulates RANKL-induced osteoclast differentiation.

Authors:  Bang Ung Youn; Kabsun Kim; Jung Ha Kim; Jongwon Lee; Jang Bae Moon; Inyoung Kim; Yong-Wook Park; Nacksung Kim
Journal:  Mol Cells       Date:  2013-08-29       Impact factor: 5.034

7.  Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors:  Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

8.  PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

Authors:  Tomohiro Hikata; Hironari Takaishi; Jiro Takito; Akihiro Hakozaki; Mitsuru Furukawa; Shinichi Uchikawa; Tokuhiro Kimura; Yasunori Okada; Masahito Matsumoto; Akihiko Yoshimura; Riko Nishimura; Sakamuri V Reddy; Hiroshi Asahara; Yoshiaki Toyama
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

9.  The 19S proteasomal lid subunit POH1 enhances the transcriptional activation by Mitf in osteoclasts.

Authors:  Toni Schwarz; Chee Sohn; Bria Kaiser; Eric D Jensen; Kim C Mansky
Journal:  J Cell Biochem       Date:  2010-04-01       Impact factor: 4.429

10.  Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis.

Authors:  April S Chan; Kristian K Jensen; Dimitris Skokos; Stephen Doty; Hannah K Lederman; Rosandra N Kaplan; Shahin Rafii; Stefano Rivella; David Lyden
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.